Radimmune Therapeutics is an early-stage biotechnology company that pioneers innovative therapies. It develops antibody-targeted radiation therapeutics, also known as radioimmunotherapy and liquid radiation. An alpha-emitting and/or beta-emitting radioisotope is guided to a universal target antigen. Radimmune has developed proprietary antibodies targeting extracellular accumulations of, normally, intracellular substances.

Biotechnology

Radimmune Therapeutics

Steven R. Deitcher

Kirk Trisler

Josh Becker

The Advisory Team at Radimmune Therapeutics provides strategic guidance and expert insights to advance the company's pioneering radioimmunotherapy initiatives. Comprising experienced advisors and scientific founders, the team leverages its extensive knowledge to support the development and optimization of innovative therapies targeting extracellular accumulations of intracellular substances.

Advisory Team

About

Team members